Tuberculosis farmacorresistente: Mecanismos moleculares de Mycobacterium tuberculosis
DOI:
https://doi.org/10.33064/iycuaa2024914559Palabras clave:
Mycobacterium tuberculosis, mutación, tuberculosis fármaco-resistente, evoluciónResumen
Mycobacterium tuberculosis (M. tb), es un patógeno humano altamente exitoso debido a que puede evadir la respuesta inmunológica del hospedero, así como desarrollar fármaco-resistencia a prácticamente todos los antibióticos anti-tuberculosis que se emplean para el tratamiento de la enfermedad. El objetivo de este trabajo fue realizar una revisión descriptiva de los mecanismos del hospedero (heterogeneidad del granuloma, adhesión al tratamiento) y de M. tb (tasa de mutación in vitro e in vivo, diversidad genética, resistencia innata, tasa metabólica, heterogeneidad de las poblaciones del bacilo, y epistasis) que intervienen en el desarrollo de la fármaco-resistencia de la bacteria.
Descargas
Métricas
Citas
• Al-Saeedi, Mashael, y Sahal Al-Hajoj. 2017. «Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis». Infection and Drug Resistance 10:333-42. doi: 10.2147/IDR.S144446.
• Auld, Sara C., N. Sarita Shah, Barun Mathema, Tyler S. Brown, Nazir Ismail, Shaheed Vally Omar, James C. M. Brust, Kristin N. Nelson, Salim Allana, Angela Campbell, Koleka Mlisana, Pravi Moodley, y Neel R. Gandhi. 2018. «Extensively Drug-Resistant Tuberculosis in South Africa: Genomic Evidence Supporting Transmission in Communities». The European Respiratory Journal 52(4):1800246. doi: 10.1183/13993003.00246-2018.
• Azimi, Taher, Saeed Khoshnood, Arezoo Asadi, Mohsen Heidary, Hassan Mahmoudi, Vahab Hassan Kaviar, Masoume Hallajzadeh, y Mohammad Javad Nasiri. 2022. «Linezolid Resistance in Multidrug-Resistant Mycobacterium Tuberculosis: A Systematic Review and Meta-Analysis». Frontiers in Pharmacology 13:955050. doi: 10.3389/fphar.2022.955050.
• Blanc, Landry, Isaac B. Daudelin, Brendan K. Podell, Pei-Yu Chen, Matthew Zimmerman, Amanda J. Martinot, Rada M. Savic, Brendan Prideaux, y Véronique Dartois. 2018. «High-Resolution Mapping of Fluoroquinolones in TB Rabbit Lesions Reveals Specific Distribution in Immune Cell Types». eLife 7:e41115. doi: 10.7554/eLife.41115.
• Bloemberg, Guido V., Peter M. Keller, David Stucki, Andrej Trauner, Sonia Borrell, Tsogyal Latshang, Mireia Coscolla, Thomas Rothe, Rico Hömke, Claudia Ritter, Julia Feldmann, Bettina Schulthess, Sebastien Gagneux, y Erik C. Böttger. 2015. «Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis». The New England Journal of Medicine 373(20):1986-88. doi: 10.1056/NEJMc1505196.
• Burney, S., J. L. Caulfield, J. C. Niles, J. S. Wishnok, y S. R. Tannenbaum. 1999. «The Chemistry of DNA Damage from Nitric Oxide and Peroxynitrite». Mutation Research 424(1-2):37-49. doi: 10.1016/s0027-5107(99)00006-8.
• Cadena, Anthony M., Sarah M. Fortune, y JoAnne L. Flynn. 2017. «Heterogeneity in Tuberculosis». Nature Reviews. Immunology 17(11):691-702. doi: 10.1038/nri.2017.69.
• Castro, Rhastin A. D., Sonia Borrell, y Sebastien Gagneux. 2021. «The Within-Host Evolution of Antimicrobial Resistance in Mycobacterium Tuberculosis». FEMS Microbiology Reviews 45(4):fuaa071. doi: 10.1093/femsre/fuaa071.
• Cohen, Keira A., Abigail L. Manson, Christopher A. Desjardins, Thomas Abeel, y Ashlee M. Earl. 2019. «Deciphering Drug Resistance in Mycobacterium Tuberculosis Using Whole-Genome Sequencing: Progress, Promise, and Challenges». Genome Medicine 11(1):45. doi: 10.1186/s13073-019-0660-8.
• Cohen, Keira A., Katharine E. Stott, Vanisha Munsamy, Abigail L. Manson, Ashlee M. Earl, y Alexander S. Pym. 2020. «Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium Tuberculosis». Antimicrobial Agents and Chemotherapy 64(9):e00860-20. doi: 10.1128/AAC.00860-20.
• Dai, Enyu, Hao Zhang, Xu Zhou, Qian Song, Di Li, Lei Luo, Xinyu Xu, Wei Jiang, y Hong Ling. 2019. «MycoResistance: A Curated Resource of Drug Resistance Molecules in Mycobacteria». Database: The Journal of Biological Databases and Curation 2019. doi: 10.1093/database/baz074.
• Dartois, Véronique. 2014. «The Path of Anti-Tuberculosis Drugs: From Blood to Lesions to Mycobacterial Cells». Nature Reviews. Microbiology 12(3):159-67. doi: 10.1038/nrmicro3200.
• Dulberger, Charles L., Eric J. Rubin, y Cara C. Boutte. 2020. «The Mycobacterial Cell Envelope — a Moving Target». Nature Reviews Microbiology 18(1):47-59. doi: 10.1038/s41579-019-0273-7.
• Eldholm, Vegard, Gunnstein Norheim, Bent von der Lippe, Wibeke Kinander, Ulf R. Dahle, Dominique A. Caugant, Turid Mannsåker, Anne Torunn Mengshoel, Anne Ma Dyrhol-Riise, y Francois Balloux. 2014. «Evolution of Extensively Drug-Resistant Mycobacterium Tuberculosis from a Susceptible Ancestor in a Single Patient». Genome Biology 15(11):490. doi: 10.1186/s13059-014-0490-3.
• Fearns, Antony, Daniel J. Greenwood, Angela Rodgers, Haibo Jiang, y Maximiliano G. Gutierrez. 2020. «Correlative Light Electron Ion Microscopy Reveals in Vivo Localisation of Bedaquiline in Mycobacterium Tuberculosis-Infected Lungs». PLoS Biology 18(12):e3000879. doi: 10.1371/journal.pbio.3000879.
• Gagneux, Sebastien. 2018. «Ecology and Evolution of Mycobacterium Tuberculosis». Nature Reviews Microbiology 16(4):202-13. doi: 10.1038/nrmicro.2018.8.
• Georghiou, Sophia B., Marisa Magana, Richard S. Garfein, Donald G. Catanzaro, Antonino Catanzaro, y Timothy C. Rodwell. 2012. «Evaluation of Genetic Mutations Associated with Mycobacterium Tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review». PloS One 7(3):e33275. doi: 10.1371/journal.pone.0033275.
• Ghosh, Abhirupa, Saran N, y Sudipto Saha. 2020. «Survey of Drug Resistance Associated Gene Mutations in Mycobacterium Tuberculosis, ESKAPE and Other Bacterial Species». Scientific Reports 10(1):8957. doi: 10.1038/s41598-020-65766-8.
• Gygli, Sebastian M., Sonia Borrell, Andrej Trauner, y Sebastien Gagneux. 2017. «Antimicrobial Resistance in Mycobacterium Tuberculosis: Mechanistic and Evolutionary Perspectives». FEMS Microbiology Reviews 41(3):354-73. doi: 10.1093/femsre/fux011.
• Hameed, H. M. Adnan, Yaoju Tan, Md Mahmudul Islam, Lingmin Guo, Chiranjibi Chhotaray, Shuai Wang, Zhiyong Liu, Yamin Gao, Shouyong Tan, Wing Wai Yew, Nanshan Zhong, Jianxiong Liu, y Tianyu Zhang. 2019. «Phenotypic and Genotypic Characterization of Levofloxacin- and Moxifloxacin-Resistant Mycobacterium Tuberculosis Clinical Isolates in Southern China». Journal of Thoracic Disease 11(11):4613-25. doi: 10.21037/jtd.2019.11.03.
• Hartkoorn, Ruben C., Swapna Uplekar, y Stewart T. Cole. 2014. «Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium Tuberculosis». Antimicrobial Agents and Chemotherapy 58(5):2979-81. doi: 10.1128/AAC.00037-14.
• Ismail, Nabila, Nazir A. Ismail, Shaheed V. Omar, y Remco P. H. Peters. 2019. «In Vitro Study of Stepwise Acquisition of Rv0678 and atpE Mutations Conferring Bedaquiline Resistance». Antimicrobial Agents and Chemotherapy 63(8):e00292-19. doi: 10.1128/AAC.00292-19.
• Jones, Richard M., Kristin N. Adams, Hassan E. Eldesouky, y David R. Sherman. 2022. «The evolving biology of Mycobacterium tuberculosis drug resistance». Frontiers in Cellular and Infection Microbiology 12.
• Kaniga, Koné, Rumina Hasan, Ruwen Jou, Edita Vasiliauskienė, Charoen Chuchottaworn, Nazir Ismail, Beverly Metchock, Skaidrius Miliauskas, Nguyen Viet Nhung, Camilla Rodrigues, Soyoun Shin, Hulya Simsek, Saijai Smithtikarn, Anh Le Thi Ngoc, Jirakan Boonyasopun, Mubin Kazi, Seungmo Kim, Phalin Kamolwat, Greta Musteikiene, Catherine Ann Sacopon, Sabira Tahseen, Laima Vasiliauskaitė, Mei-Hua Wu, y Shaheed Vally Omar. 2022. «Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): A 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates». Journal of Clinical Microbiology 60(1):e0291920. doi: 10.1128/JCM.02919-20.
• Kreutzfeldt, Kaj M., Robert S. Jansen, Travis E. Hartman, Alexandre Gouzy, Ruojun Wang, Inna V. Krieger, Matthew D. Zimmerman, Martin Gengenbacher, Jansy P. Sarathy, Min Xie, Véronique Dartois, James C. Sacchettini, Kyu Y. Rhee, Dirk Schnappinger, y Sabine Ehrt. 2022. «CinA Mediates Multidrug Tolerance in Mycobacterium Tuberculosis». Nature Communications 13(1):2203. doi: 10.1038/s41467-022-29832-1.
• Lavin, Richard C., y Shumin Tan. 2022. «Spatial Relationships of Intra-Lesion Heterogeneity in Mycobacterium Tuberculosis Microenvironment, Replication Status, and Drug Efficacy». PLoS Pathogens 18(3):e1010459. doi: 10.1371/journal.ppat.1010459.
• Laws, Mark, Peiqin Jin, y Khondaker Miraz Rahman. 2022. «Efflux Pumps in Mycobacterium Tuberculosis and Their Inhibition to Tackle Antimicrobial Resistance». Trends in Microbiology 30(1):57-68. doi: 10.1016/j.tim.2021.05.001.
• Lenaerts, Anne, Clifton E. Barry, y Véronique Dartois. 2015. «Heterogeneity in Tuberculosis Pathology, Microenvironments and Therapeutic Responses». Immunological Reviews 264(1):288-307. doi: 10.1111/imr.12252.
• Malinga, L., J. Brand, C. Jansen van Rensburg, G. Cassell, y M. van der Walt. 2016. «Investigation of Isoniazid and Ethionamide Cross-Resistance by Whole Genome Sequencing and Association with Poor Treatment Outcomes of Multidrug-Resistant Tuberculosis Patients in South Africa». International Journal of Mycobacteriology 5 Suppl 1:S36-37. doi: 10.1016/j.ijmyco.2016.11.020.
• Mann, Katherine M., Aaron C. Pride, Kelly Flentie, Jacqueline M. Kimmey, Leslie A. Weiss, y Christina L. Stallings. 2016. «Analysis of the contribution of MTP and the predicted Flp pilus genes to Mycobacterium tuberculosis pathogenesis». Microbiology, 162(10):1784-96. doi: 10.1099/mic.0.000368.
• Mariam, Solomon H., Jim Werngren, Joakim Aronsson, Sven Hoffner, y Dan I. Andersson. 2011. «Dynamics of Antibiotic Resistant Mycobacterium Tuberculosis during Long-Term Infection and Antibiotic Treatment». PLOS ONE 6(6):e21147. doi: 10.1371/journal.pone.0021147.
• Maus, Courtney E., Bonnie B. Plikaytis, y Thomas M. Shinnick. 2005. «Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium Tuberculosis». Antimicrobial Agents and Chemotherapy 49(8):3192-97. doi: 10.1128/AAC.49.8.3192-3197.2005.
• McGrath, M., N. C. Gey van Pittius, P. D. van Helden, R. M. Warren, y D. F. Warner. 2014. «Mutation Rate and the Emergence of Drug Resistance in Mycobacterium Tuberculosis». The Journal of Antimicrobial Chemotherapy 69(2):292-302. doi: 10.1093/jac/dkt364.
• Migliori, G. B., G. De Iaco, G. Besozzi, R. Centis, y D. M. Cirillo. 2007. «First Tuberculosis Cases in Italy Resistant to All Tested Drugs». Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 12(5):E070517.1.
• Mitchison, D. A. 1980. «Treatment of Tuberculosis». Journal of the Royal College of Physicians of London 14(2):91-99.
• Müller, Borna, Sonia Borrell, Graham Rose, y Sebastien Gagneux. 2013. «The Heterogeneous Evolution of Multidrug-Resistant Mycobacterium Tuberculosis». Trends in Genetics: TIG 29(3):160-69. doi: 10.1016/j.tig.2012.11.005.
• Newton, Gerald L., Nancy Buchmeier, y Robert C. Fahey. 2008. «Biosynthesis and Functions of Mycothiol, the Unique Protective Thiol of Actinobacteria». Microbiology and Molecular Biology Reviews: MMBR 72(3):471-94. doi: 10.1128/MMBR.00008-08.
• Nguyen, Quang Huy, Lucie Contamin, Thi Van Anh Nguyen, y Anne-Laure Bañuls. 2018. «Insights into the Processes That Drive the Evolution of Drug Resistance in Mycobacterium Tuberculosis». Evolutionary Applications 11(9):1498-1511. doi: 10.1111/eva.12654.
• Ordonez, Alvaro A., Hechuan Wang, Gesham Magombedze, Camilo A. Ruiz-Bedoya, Shashikant Srivastava, Allen Chen, Elizabeth W. Tucker, Michael E. Urbanowski, Lisa Pieterse, E. Fabian Cardozo, Martin A. Lodge, Maunank R. Shah, Daniel P. Holt, William B. Mathews, Robert F. Dannals, Jogarao V. S. Gobburu, Charles A. Peloquin, Steven P. Rowe, Tawanda Gumbo, Vijay D. Ivaturi, y Sanjay K. Jain. 2020. «Dynamic Imaging in Patients with Tuberculosis Reveals Heterogeneous Drug Exposures in Pulmonary Lesions». Nature Medicine 26(4):529-34. doi: 10.1038/s41591-020-0770-2.
• Poulton, Nicholas C., y Jeremy M. Rock. 2022. «Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis». Frontiers in Cellular and Infection Microbiology 12.
• Prideaux, Brendan, Laura E. Via, Matthew D. Zimmerman, Seokyong Eum, Jansy Sarathy, Paul O’Brien, Chao Chen, Firat Kaya, Danielle M. Weiner, Pei-Yu Chen, Taeksun Song, Myungsun Lee, Tae Sun Shim, Jeong Su Cho, Wooshik Kim, Sang Nae Cho, Kenneth N. Olivier, Clifton E. Barry, y Véronique Dartois. 2015. «The Association between Sterilizing Activity and Drug Distribution into Tuberculosis Lesions». Nature Medicine 21(10):1223-27. doi: 10.1038/nm.3937.
• Reichmuth, Martina L., Rico Hömke, Kathrin Zürcher, Peter Sander, Anchalee Avihingsanon, Jimena Collantes, Chloé Loiseau, Sonia Borrell, Miriam Reinhard, Robert J. Wilkinson, Marcel Yotebieng, Lukas Fenner, Erik C. Böttger, Sebastien Gagneux, Matthias Egger, y Peter M. Keller. 2020. «Natural Polymorphisms in Mycobacterium Tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients». Antimicrobial Agents and Chemotherapy 64(11):e00513-20. doi: 10.1128/AAC.00513-20.
• Rengarajan, Jyothi, Christopher M. Sassetti, Vera Naroditskaya, Alexander Sloutsky, Barry R. Bloom, y Eric J. Rubin. 2004. «The Folate Pathway Is a Target for Resistance to the Drug Para-Aminosalicylic Acid (PAS) in Mycobacteria». Molecular Microbiology 53(1):275-82. doi: 10.1111/j.1365-2958.2004.04120.x.
• Rocha, Deisy M. G. C., Miguel Viveiros, Margarida Saraiva, y Nuno S. Osório. 2021. «The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem». Genes 12(12):2003. doi: 10.3390/genes12122003.
• Rueda, Johana, Teresa Realpe, Gloria Isabel Mejia, Elsa Zapata, Juan Carlos Rozo, Beatriz Eugenia Ferro, y Jaime Robledo. 2015. «Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium Tuberculosis Clinical Isolates». Antimicrobial Agents and Chemotherapy 59(12):7805-10. doi: 10.1128/AAC.01028-15.
• Sandgren, Andreas, Michael Strong, Preetika Muthukrishnan, Brian K. Weiner, George M. Church, y Megan B. Murray. 2009. «Tuberculosis Drug Resistance Mutation Database». PLoS Medicine 6(2):e2. doi: 10.1371/journal.pmed.1000002.
• Santucci, Pierre, Beren Aylan, Laure Botella, Elliott M. Bernard, Claudio Bussi, Enrica Pellegrino, Natalia Athanasiadi, y Maximiliano G. Gutierrez. 2022. «Visualizing Pyrazinamide Action by Live Single-Cell Imaging of Phagosome Acidification and Mycobacterium tuberculosis pH Homeostasis». mBio 13(2):e00117-22. doi: 10.1128/mbio.00117-22.
• Santucci, Pierre, Daniel J. Greenwood, Antony Fearns, Kai Chen, Haibo Jiang, y Maximiliano G. Gutierrez. 2021. «Intracellular Localisation of Mycobacterium Tuberculosis Affects Efficacy of the Antibiotic Pyrazinamide». Nature Communications 12(1):3816. doi: 10.1038/s41467-021-24127-3.
• Shi, Jie, Ruyue Su, Danwei Zheng, Yankun Zhu, Xiaoguang Ma, Shaohua Wang, Hui Li, y Dingyong Sun. 2020. «Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium Tuberculosis from Henan Province». Infection and Drug Resistance 13:2929-41. doi: 10.2147/IDR.S260161.
• Sun, Gang, Tao Luo, Chongguang Yang, Xinran Dong, Jing Li, Yongqiang Zhu, Huajun Zheng, Weidong Tian, Shengyue Wang, Clifton E. Barry, III, Jian Mei, y Qian Gao. 2012. «Dynamic Population Changes in Mycobacterium Tuberculosis During Acquisition and Fixation of Drug Resistance in Patients». The Journal of Infectious Diseases 206(11):1724. doi: 10.1093/infdis/jis601.
• Udwadia, Zarir F., Rohit A. Amale, Kanchan K. Ajbani, y Camilla Rodrigues. 2012. «Totally drug-resistant tuberculosis in India». Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(4):579-81. doi: 10.1093/cid/cir889.
• Velayati, Ali Akbar, Mohammad Reza Masjedi, Parissa Farnia, Payam Tabarsi, Jalladein Ghanavi, Abol Hassan ZiaZarifi, y Sven Eric Hoffner. 2009. «Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli: Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran». Chest 136(2):420-25. doi: 10.1378/chest.08-2427.
• Vilchèze, Catherine. 2020. «Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs». Applied Sciences 10(7):2278. doi: 10.3390/app10072278.
• Walker, TM, Miotto P, Köser Cu, Fowler Pw, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo Dm, Comas I, Posey J, Omar Sv, Peto Te, Suresh A, Uplekar S, Laurent S, Colman Re, Nathanson Cm, Zignol M, Walker As, Crook Dw, Ismail N, y Rodwell Tc. 2022. «The 2021 WHO Catalogue of Mycobacterium Tuberculosis Complex Mutations Associated with Drug Resistance: A Genotypic Analysis». The Lancet. Microbe 3(4). doi: 10.1016/S2666-5247(21)00301-3.
• Warner, Digby F., y Valerie Mizrahi. 2006. «Tuberculosis Chemotherapy: The Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy». Clinical Microbiology Reviews 19(3):558-70. doi: 10.1128/CMR.00060-05.
• Warner, Digby F., Jeremy M. Rock, Sarah M. Fortune, y Valerie Mizrahi. 2017. «DNA Replication Fidelity in the Mycobacterium Tuberculosis Complex». Advances in Experimental Medicine and Biology 1019:247-62. doi: 10.1007/978-3-319-64371-7_13.
• WHO. 2019. «Farmacorresistencia a los antituberculosos». Recuperado (https://www.who.int/tb/areas-of-work/drug-resistant-tb/es/).
• WHO. 2021. «Catalogue of Mutations in Mycobacterium Tuberculosis Complex and Their Association with Drug Resistance». Recuperado 27 de septiembre de 2022 (https://www.who.int/publications-detail-redirect/9789240028173).
• WHO. 2022. Global Tuberculosis Report 2022. Geneva, Switzerland: WHO.
• Zhang, Xiaobing, Liguo Liu, Yan Zhang, Guangming Dai, Hairong Huang, y Qi Jin. 2015. «Genetic Determinants Involved in P-Aminosalicylic Acid Resistance in Clinical Isolates from Tuberculosis Patients in Northern China from 2006 to 2012». Antimicrobial Agents and Chemotherapy 59(2):1320-24. doi: 10.1128/AAC.03695-14.
• Zhang, Xiaofu, Xi Chen, Bin Wang, Lei Fu, Fengmin Huo, Tianhui Gao, Yu Pang, Yu Lu, y Qi Li. 2022. «Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium Tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis». Microbial Drug Resistance (Larchmont, N.Y.) 28(3):280-87. doi: 10.1089/mdr.2021.0212.
• Zhang, Ying, Wanliang Shi, Wenhong Zhang, y Denis Mitchison. 2014. «Mechanisms of Pyrazinamide Action and Resistance». Microbiology Spectrum 2(4):MGM2-0023-2013. doi: 10.1128/microbiolspec.MGM2-0023-2013.
• Zong, Zhaojing, Wei Jing, Jin Shi, Shu’an Wen, Tingting Zhang, Fengmin Huo, Yuanyuan Shang, Qian Liang, Hairong Huang, y Yu Pang. 2018. «Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium Tuberculosis in China». Antimicrobial Agents and Chemotherapy 62(8):e00165-18. doi: 10.1128/AAC.00165-18.
Descargas
Publicado
Cómo citar
Licencia
Derechos de autor 2024 Anaximandro Gomez-Velasco, René Armando Rodríguez-Suárez, Pilar E. Granja-Pérez, Salha M. Villanueva-Jorge, José Q. García-Maldonado
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Las obras publicadas en versión electrónica de la revista están bajo la licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
